Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,038.00    3.00 (0.29%)
Bid:
1,037.00
Ask:
1,038.00
Spread: 1.00 (0.096%)
Market Cap: £5.08b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

AGM Trading Update

26 Sep 2022 07:00

RNS Number : 5364A
Babcock International Group PLC
26 September 2022
 

26 September 2022

AGM trading update - Continued progress. Full year expectations unchanged

 

Babcock International Group PLC ("Babcock" or "the Group") provides a trading update for the first five months of the year ahead of its Annual General Meeting to be held at 2pm today.

Trading continues to be in line with the Board's expectations for the full year.

Market

The market backdrop remains dynamic. Ongoing geopolitical uncertainty is leading to increased national defence requirements and potentially more opportunities, while macro factors such as inflation and supply chain stress increase delivery challenges.

Group trading for the first five months of the year

Overall group revenue and profit in the first five months of FY23 was in line with expectations. Organic revenue growth is largely offsetting the impact of disposals made in the prior year. Operating profit is being driven by our focus on execution and the efficiencies we are realising from our new operating model.

As previously guided, we anticipate a net cash outflow in the first half of FY23, reflecting the timing of pension deficit payments, with a return to positive free cash flow in the second half. Overall, our expectations of trading for the full year are unchanged.

Order momentum remains good. We have won a number of new contract awards in the period, including a 10-year support contract for the Queen Elizabeth class aircraft carriers, multiple orders for LGE equipment, two further contracts relating to Poland's frigate programme, MIECZNIK (Swordfish), and renewal of the Royal Air Force's Hawk fleet support contract at RAF Valley, in an 11-year agreement.

Disposals

 

We have continued to progress our portfolio alignment programme to focus the Group and reduce complexity. On 19 July 2022 we announced an agreement with Ancala Partners for the sale of certain aerial emergency services business, for a gross cash consideration of €136.2 million. We expect to complete this transaction before the end of the calendar year.

 

Ends

 

For further information:

 

Andrew Gollan, Babcock Director of Investor Relations

+44 (0)7936 039 004

Kate Hill, Babcock Group Director of Communications

+44 (0)20 7355 5312

Olivia Peters / Harry Cameron, Tulchan Communications

+44 (0)20 7353 4200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGZLVKVGZZM
Date   Source Headline
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202611:21 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 202610:17 amRNSDirector/PDMR Shareholding
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSBabcock announces CEO retirement and succession
23rd Jan 20267:00 amRNSQ3 trading update – strong delivery underpins FY
21st Jan 202611:05 amRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202610:06 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20252:57 pmRNSDirector/PDMR Shareholding
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.